|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Mumps Virus IgG ELISA | Amyloid Beta Oligomers (82E1-specific) ELISA Assay | Anti-Trastuzumab (Herceptin®) ELISA | Pancreatic Polypeptide RIA Assay | Vitamin D (25OH) (Free) ELISA Assay |
| Citations | | | | | |
| Catalog Number | IB79882 | 27725 | TM09015 | RB316 US | KARF1991 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | The Mumps Virus IgG ELISA is intended for the qualitative determination of IgG class antibodies against Mumps Virus in human serum or plasma (citrate, heparin). FDA exempt, can be used for in-vitro diagnostics. | Solid phase sandwich ELISA for the determination of human Aß molecules which bind to nti-human Aß (N) (82E1) mouse MoAb with two or more epitopes (oligomers, polymers with a protein etc.) in serum, EDTA-plasma and brain tissue extract. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Trastuzumab (Herceptin®, Herclon®) in serum and plasma. For research use only, not for use in diagnostic procedures. | Radioimmunoassay (RIA) for the determination Pancreatic Polypeptide (PP) in human serum. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) for determination of free 25 (OH) Vitamin D in serum. For research use only, not for use in diagnostic procedures. |
| Detection Target | Tocilizumab (Actemra®) (mAb-based) | a-Synuclein | Ranibizumab (Lucentis®) (mAb-based) | Glutamate | PMN Elastase |
| Sample Type | Serum and plasma. | Serum, Blood Plasma, CSF, Cell Culture Supernatant | Aqueous humour | Urine, Serum, Blood Plasma | Blood Plasma, Exudate, Bronchoalveolar Lavage Fluid, CSF, Seminal Plasma |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Radio Immuno Assay (RIA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | A cut-off control is used for the interpretation of results. | 18.98 to 1215 pmol/L | 0 / 30 - 1000 ng/mL | 6.25 to 200 pmol/L | 0 to 40 pg/mL |
| Sensitivity | 2 ng/mL | 0.03 ng/mL | 0.33 ng/mL | 0.3 µg/mL | 0.2 ng/mL |
| Assay Time | 1 hr, 45 mins (incubation) | 2 hrs 30 mins (incubation) | 2 hours, 15 min. total incubation time. | 40 to 48 hrs 45 mins (incubation) | 2 hrs, 35 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |